NO20011763D0 - Midler for å retardere endring av hormonavhengig cancer til hormonuavhengig cancer - Google Patents

Midler for å retardere endring av hormonavhengig cancer til hormonuavhengig cancer

Info

Publication number
NO20011763D0
NO20011763D0 NO20011763A NO20011763A NO20011763D0 NO 20011763 D0 NO20011763 D0 NO 20011763D0 NO 20011763 A NO20011763 A NO 20011763A NO 20011763 A NO20011763 A NO 20011763A NO 20011763 D0 NO20011763 D0 NO 20011763D0
Authority
NO
Norway
Prior art keywords
dependent cancer
hormone dependent
retard
change
hormone
Prior art date
Application number
NO20011763A
Other languages
English (en)
Other versions
NO20011763L (no
Inventor
Etsuya Matsutani
Kenichiro Naito
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20011763D0 publication Critical patent/NO20011763D0/no
Publication of NO20011763L publication Critical patent/NO20011763L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20011763A 1998-10-08 2001-04-06 Middel som forsinker transformasjon av hormonavhengig kreft til hormonuavhengig kreft NO20011763L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28679398 1998-10-08
PCT/JP1999/005533 WO2000020034A1 (fr) 1998-10-08 1999-10-07 Agents destines a retarder le passage d'un cancer hormono-dependant a un cancer hormono-independant

Publications (2)

Publication Number Publication Date
NO20011763D0 true NO20011763D0 (no) 2001-04-06
NO20011763L NO20011763L (no) 2001-06-07

Family

ID=17709122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011763A NO20011763L (no) 1998-10-08 2001-04-06 Middel som forsinker transformasjon av hormonavhengig kreft til hormonuavhengig kreft

Country Status (9)

Country Link
US (1) US20060135435A1 (no)
EP (1) EP1136079A4 (no)
KR (1) KR20010080007A (no)
CN (1) CN1322139A (no)
AU (1) AU6004999A (no)
CA (1) CA2345213A1 (no)
HU (1) HUP0103761A3 (no)
NO (1) NO20011763L (no)
WO (1) WO2000020034A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1382350A4 (en) * 2001-04-25 2006-01-04 Takeda Pharmaceutical MEANS AGAINST THE PROPHYLAXIS BEFORE POSTOPERATIVE REPEAT OF PREMOPEOPAUSAL BREAST CANCER
WO2002087618A1 (fr) * 2001-04-27 2002-11-07 Takeda Chemical Industries, Ltd. Methode de prevention et de traitement du cancer
WO2002087619A1 (fr) * 2001-04-27 2002-11-07 Takeda Chemical Industries, Ltd. Methode de prevention et de traitement du cancer
US7812044B2 (en) 2001-11-13 2010-10-12 Takeda Pharmaceutical Company Limited Anticancer agents
WO2003075958A1 (fr) 2002-03-11 2003-09-18 Takeda Chemical Industries, Ltd. Medicaments permettant de traiter une maladie dependant d'une hormone sexuelle
BR0313405A (pt) 2002-08-12 2005-07-12 Takeda Pharmaceutical Compostos, métodos para preparar um composto e para prevenir e/ou tratar câncer, prodroga, medicamento, modulador do receptor de androgênio, agente para prevenir e/ou tratar hipogonadismo ou pertubação climatérica masculina, osteoporose e câncer, e, uso de um composto
US8497691B2 (en) 2007-06-28 2013-07-30 Frymaster L.L.C. Oil quality sensor and adapter for deep fryers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
WO1989006692A1 (en) * 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
DE69736642T2 (de) * 1996-07-19 2007-09-20 Takeda Pharmaceutical Co. Ltd. Heterocyclische Verbindungen, ihre Herstellung und Verwendung
AU5678398A (en) * 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
UA61970C2 (en) * 1997-08-15 2003-12-15 Combined use of tyrosine kinase inhibitor and a chemical castration agent for treating prostate cancer
PE20011178A1 (es) * 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion

Also Published As

Publication number Publication date
HUP0103761A2 (hu) 2002-02-28
WO2000020034A1 (fr) 2000-04-13
AU6004999A (en) 2000-04-26
HUP0103761A3 (en) 2002-11-28
CA2345213A1 (en) 2000-04-13
KR20010080007A (ko) 2001-08-22
US20060135435A1 (en) 2006-06-22
EP1136079A4 (en) 2004-09-22
NO20011763L (no) 2001-06-07
CN1322139A (zh) 2001-11-14
EP1136079A1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
NO20014607D0 (no) Sammensetninger til forbedring av fertilitet
EE200000437A (et) Tselekoksiibiühendid
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
EE200100600A (et) FAP-aktiveeritud kasvajavastased ühendid
DE59902470D1 (de) Neue 2-heterocyclisch substituierte dihydropyrimidine
ZA9811898B (en) Anti-Inflammatory Compounds.
NO992732L (no) Parasitticidale forbindelser
NO20006280D0 (no) Innretning for emisjon av enkeltfotnoter
TR199900853A3 (tr) Sübstitüe edilmis trisiklik bilesikler.
NO992692L (no) Nefadozon doseringsform
NO20011403L (no) Terapi for å forbedre kongestion
NO20013507D0 (no) Sammensetning til å behandle inflammatorisk respons
DE69807998T2 (de) Hydraulische Drehphaseneinstellvorrichtung
NO974972D0 (no) Fremgangsmåte for å hindre brystcancer
DE50015811D1 (de) Retardersystem
ID16929A (id) Komposisi anti vaginitis untuk penggunaan topikal.
DE69830314D1 (de) Phasenregler
DE59911248D1 (de) Halterung
DE59914584D1 (de) Organisch-anorganischer Mörtel
NO20011763D0 (no) Midler for å retardere endring av hormonavhengig cancer til hormonuavhengig cancer
DE50015381D1 (de) Retardersystem
FI980095A0 (fi) Foerfarande foer byggande av fartyg
TW420175U (en) Structure improvement for the driveway retarding
NO20013575D0 (no) Fremgangsmåte for å gjöre det lettere å stoppe å röke
DK199800365U3 (da) Beslag til løfteport

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application